BIOGEN INC. DL -,0005/ US09062X1037 /
| 07/11/2024 21:48:27 | Chg. -1.45 | Volume | Bid07/11/2024 | Ask07/11/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 160.85EUR | -0.89% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 23.46 bill.EUR | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 8.02 USD | -61.74% |
| EPS Diluted: | 7.97 USD | -61.81% |
| Revenues per Share: | 67.66 USD | -3.90% |
| Book Value per Share: | 101.81 USD | 9.87% |
| Cash Flow per Share: | 10.64 USD | 11.09% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 9,835.60 USD | -3.32% |
| Net Income: | 1,161.10 USD | -61.89% |
| Operating Cash Flow: | 1,547.20 USD | - |
| Cash and Cash Equivalents: | 1,049.90 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 21.69 | 32.27 |
| P/S Ratio: | 2.57 | 3.82 |
| P/BV ratio: | 1.71 | 2.54 |
| P/CF Ratio: | 16.34 | 24.31 |
| PEG: | -0.35 | -0.52 |
| Earnings Yield: | 4.61% | 3.10% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 23.46 bill. EUR | 34.07 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 145.72 mill. | |
Profitability
| Gross Profit Margin: | 74.24% |
| EBIT Margin: | 0.00% |
| Net Profit Margin: | 11.81% |
| Return on Equity: | 7.85% |
| Return on Assets: | 4.33% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.31% |
| Liquidity II / Quick Ratio: | 0.79% |
| Liquidity III / Current Ratio: | 2.00% |
| Debt / Equity Ratio: | 0.47% |
| Dynam. Debt / Equity Ratio: | 778.53% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 31/12/2023 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
